Wikidata

(Q61939305)

English

Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

title
Metabolic Profile and Cardiovascular Biomarker Pattern Compared in naíve Patients Initiating HAART With TDF-FTC and Raltegravir 400mg BID Vs Darunavir 800 mg Plus Ritonavir 100 mg QD; a One Year Follow-up Observational Study (English)
0 references
country
Spain
0 references
main subject
HIV
0 references
start time
February 2010
0 references
end time
January 2011
0 references
number of participants
120
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61939305&oldid=2167898659"